Steffen Pietzke has been chief financial officer since joining Enovix in April 2021. He is responsible for leading all financial operations and planning.
Steffen has more than 20 years of experience guiding public and private technology, life science and transportation companies across the U.S., Europe and Asia. Before joining Enovix, Steffen was vice president, finance and chief accounting officer at ALX Oncology Holdings, Inc., where he managed all facets of corporate accounting and finance. Prior to ALX Oncology, Steffen was senior vice president, finance and chief accounting officer at Tricida, Inc. Among his accomplishments, Pietzke has successfully managed finance organizations during two initial public offerings — ALX Oncology's $186 million IPO in 2020 and Tricida's $256 million IPO in 2018.
Prior to joining Tricida, Steffen was vice president, finance and chief accounting officer at PDL BioPharma. He spent the first fifteen years of his career at Ernst & Young LLP and PricewaterhouseCoopers, where he worked in Switzerland, China and Silicon Valley.
Steffen holds a bachelor of business science in accounting from the University of Applied Sciences in Offenburg, Germany and is a certified public accountant.